Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome

被引：0
|
作者：
Shuichiro Fujinaga
Koji Sakuraya
Akifumi Yamada
Yasuko Urushihara
Yoshiyuki Ohtomo
Toshiaki Shimizu
机构：
[1] Saitama Children’s Medical Center,Division of Nephrology
[2] Juntendo Nerima Hospital,Department of Pediatrics
[3] Juntendo University School of Medicine,Department of Pediatrics
来源：
Pediatric Nephrology | 2015年 / 30卷
关键词：
Nephrotic Syndrome; Mycophenolate Mofetil; Minimal Change Disease; Nephrotic Syndrome Patient; Nephrotic Syndrome Relapse;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：687 / 691
页数：4
相关论文
共 50 条
  • [1] Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome
    Fujinaga, Shuichiro
    Sakuraya, Koji
    Yamada, Akifumi
    Urushihara, Yasuko
    Ohtomo, Yoshiyuki
    Shimizu, Toshiaki
    PEDIATRIC NEPHROLOGY, 2015, 30 (04) : 687 - 691
  • [2] Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome
    Bagga, A
    Hari, P
    Moudgil, A
    Jordan, SC
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (06) : 1114 - 1120
  • [3] Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome
    Al-Akash, S
    Al Makdama, A
    ANNALS OF SAUDI MEDICINE, 2005, 25 (05) : 380 - 384
  • [4] Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome
    Dehoux, Laurene
    Hogan, Julien
    Dossier, Claire
    Fila, Marc
    Niel, Olivier
    Maisin, Anne
    Macher, Marie Alice
    Kwon, Theresa
    Baudouin, Veronique
    Deschenes, Georges
    PEDIATRIC NEPHROLOGY, 2016, 31 (11) : 2095 - 2101
  • [5] Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome
    Laurène Dehoux
    Julien Hogan
    Claire Dossier
    Marc Fila
    Olivier Niel
    Anne Maisin
    Marie Alice Macher
    Thérésa Kwon
    Véronique Baudouin
    Georges Deschênes
    Pediatric Nephrology, 2016, 31 : 2095 - 2101
  • [6] Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab
    Shuichiro Fujinaga
    Tomonosuke Someya
    Tsuneki Watanabe
    Akira Ito
    Yoshiyuki Ohtomo
    Toshiaki Shimizu
    Kazunari Kaneko
    European Journal of Pediatrics, 2013, 172 : 513 - 518
  • [7] Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab
    Fujinaga, Shuichiro
    Someya, Tomonosuke
    Watanabe, Tsuneki
    Ito, Akira
    Ohtomo, Yoshiyuki
    Shimizu, Toshiaki
    Kaneko, Kazunari
    EUROPEAN JOURNAL OF PEDIATRICS, 2013, 172 (04) : 513 - 518
  • [8] Efficacy of maintenance therapy with mycophenolate mofetil after rituximab for steroid-dependent nephrotic syndrome
    Ito, Shuichi
    Tsutsumi, Akiko
    Noda, Shunsuke
    Udagawa, Tomohiro
    Ogura, Masao
    Sako, Mayumi
    Kamei, Koichi
    Iijima, Kazumoto
    PEDIATRIC NEPHROLOGY, 2011, 26 (05) : 829 - 829
  • [9] Should mycophenolate mofetil be administered prior to cyclosporine A as a steroid-sparing agent to children with steroid-dependent nephrotic syndrome?
    Shuichiro Fujinaga
    Koji Sakuraya
    Pediatric Nephrology, 2018, 33 : 2389 - 2390
  • [10] Should mycophenolate mofetil be administered prior to cyclosporine A as a steroid-sparing agent to children with steroid-dependent nephrotic syndrome?
    Fujinaga, Shuichiro
    Sakuraya, Koji
    PEDIATRIC NEPHROLOGY, 2018, 33 (12) : 2389 - 2390
12345